# Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Fluviral® (2012/2013 Season) in Adults

> **NCT01626820** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 113 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Fluviral®

## Key facts

- **NCT ID:** NCT01626820
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07-19
- **Primary completion:** 2012-08-10
- **Final completion:** 2012-08-10
- **Target enrollment:** 113 (ACTUAL)
- **Last updated:** 2018-09-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01626820

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01626820, "Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Fluviral® (2012/2013 Season) in Adults". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01626820. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*